Amylyx Pharmaceuticals Etf Analysis

Amylyx Etf Analysis Notes

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange. For more info on Amylyx Pharmaceuticals please contact Justin Klee at 617 682 0917 or go to https://amylyx.com.

Amylyx Pharmaceuticals Investment Alerts

Amylyx Pharmaceuticals Upcoming and Recent Events

Amylyx Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amylyx Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Amylyx Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Top Amylyx Pharmaceuticals Etf Constituents

Technical Drivers

As of the 16th of September 2025, Amylyx Pharmaceuticals shows the Mean Deviation of 3.36, downside deviation of 3.1, and Risk Adjusted Performance of 0.2118. Amylyx Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.

Amylyx Pharmaceuticals Price Movement Analysis

Amylyx Pharmaceuticals Insider Trading Activities

Amylyx Pharmaceuticals Outstanding Bonds

Amylyx Pharmaceuticals Predictive Daily Indicators

Amylyx Pharmaceuticals Forecast Models

Amylyx Pharmaceuticals' time-series forecasting models are one of many Amylyx Pharmaceuticals' etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amylyx Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Etf analysis is the technique used by a trader or investor to examine and evaluate how Amylyx Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amylyx shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as Amylyx Pharmaceuticals. By using and applying Amylyx Etf analysis, traders can create a robust methodology for identifying Amylyx entry and exit points for their positions.

Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.